TEAM Atlassian Corp Insider Trading

CRO Brian Duffy sells 6,245 shares ($564.5K) at $90.39 avg via scheduled 10b5-1 plan at unprofitable TEAM

Brian Duffy, Chief Revenue Officer, executed 3 separate sales totaling 6,245 shares for $564,505.55 on 2026-06-10 through 2026-06-12, sold at blended average price of $90.39. This transaction was part of a pre-arranged 10b5-1 trading plan adopted on 2026-03-06, meaning the sales were scheduled and automatic rather than discretionary. Atlassian remains unprofitable with net income of $-98,389,000.00 despite strong revenue growth of 19.7% annually; the CRO retains significant holdings of 232,123 shares post-transaction, representing a 2.6% reduction from prior holdings. The stock is currently trading at $88.52, down 60.2% from its 52-week high of $222.59, though it has recovered 9.8% over the past 30 days and 17.7% over the past 90 days.

CEO Cannon-Brookes sells 7,665 shares of TEAM for $726,715.67 via 10b5-1 plan

Cannon-Brookes executed 9 separate sales totaling 7,665 shares for $726,715.67 on 2026-02-06, reducing his holdings from 283,605 shares to 275,940 shares (a -2.7% reduction). The blended average sale price was $94.81. This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2025-02-20, meaning the sales were scheduled and not discretionary. Because the sales are subject to a pre-determined plan, they reflect prior scheduling decisions rather than current market conditions or conviction-level changes. The relatively modest scale of the reduction (-2.7% of holdings) and the structured nature of the plan are consistent with ongoing portfolio management within the framework established over a year ago.

Atlassian CEO Michael Cannon-Brookes sold 7,665 shares for $783,970.42 via scheduled 10b5-1 plan on 2026-02-05

Cannon-Brookes executed 8 separate sales totaling 7,665 shares for $783,970.42 at a blended average price of $102.28. His holdings declined from 291,270 shares to 283,605 shares, representing a 2.6% reduction. This sale was executed under a pre-arranged 10b5-1 trading plan adopted on 2025-02-20, meaning the transaction was scheduled rather than discretionary. The multi-tranche execution across different price points between $98.37 and $106.04 reflects the mechanical nature of the scheduled plan.

CEO Cannon-Brookes sold 7,665 shares at blended avg $105.14 (Feb 4) under pre-arranged 10b5-1 plan

Michael Cannon-Brookes, CEO and Co-Founder of Atlassian, executed 9 separate sales totaling 7,665 shares for $805,878.26 on 2026-02-04 at prices ranging from $99.14 to $108.24. This represents a 2.6% reduction in his holdings to 291,270 shares post-transaction. The FLAG indicates this transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2025-02-20, meaning the sales were scheduled and non-discretionary. As a scheduled execution under an adopted plan, this transaction reflects predetermined trading mechanics rather than discretionary decision-making at a specific price point.

CEO Michael Cannon-Brookes sells 7,665 shares for $797,459.44 via scheduled 10b5-1 plan adopted 2025-02-20

Michael Cannon-Brookes executed 8 separate sales totaling 7,665 shares for $797,459.44 on 2026-02-03, reducing holdings from 306,600 to 298,935 shares (a 2.5% reduction). The transaction was conducted under a pre-arranged 10b5-1 trading plan adopted 2025-02-20, meaning it was scheduled rather than discretionary. The sales occurred at prices ranging from $101.62 to $109.31, with a blended average of $104.04. As a planned, non-discretionary activity under a public trading schedule, this filing carries routine significance and does not signal timing-based conviction or concern.

Atlassian CEO Michael Cannon-Brookes sold 7,665 shares for $892,193.70 via 10b5-1 trading plan on 2026-02-02

Michael Cannon-Brookes executed six separate sales totaling 7,665 shares for $892,193.70 on 2026-02-02 at prices ranging from $114.03 to $119.29 per share, reducing his holdings from 314,265 shares to 306,600 shares. This transaction was conducted pursuant to a 10b5-1 trading plan adopted on 2025-02-20, meaning the sales were scheduled and not discretionary. The 2.4% reduction in his post-transaction holdings reflects routine portfolio management under a pre-arranged plan rather than a discretionary action signaling a change in conviction toward Atlassian.

CEO Michael Cannon-Brookes sold 7,665 shares of Atlassian (TEAM) for $913,311.35 via 10b5-1 plan on 2026-01-30.

Michael Cannon-Brookes, Atlassian's CEO and co-founder, executed 5 separate sales totaling 7,665 shares for $913,311.35 on 2026-01-30, reducing his holdings by 2.4% to 314,265 shares. The transaction was executed via a pre-arranged 10b5-1 trading plan adopted on 2025-02-20, meaning the sales were scheduled and not discretionary decisions. The blended average price of $119.15 across the five tranches reflects intraday execution across a narrow range ($118.34 to $122.60 per share). As a scheduled disposition under a pre-established plan, this sale carries no timing signal and reflects Cannon-Brookes' prior liquidity management planning rather than a current assessment of company value.

CEO Michael Cannon-Brookes sells 7,665 shares at avg $118.97 per scheduled 10b5-1 plan

Michael Cannon-Brookes (CEO, Co-Founder) executed 6 separate sales totaling 7,665 shares for $911,894.72 on 2026-01-29 across a range of prices from $116.70 to $123.17. This activity is part of a pre-arranged 10b5-1 trading plan adopted on 2025-02-20, making the transaction scheduled and non-discretionary. The sales reduced his holdings from 329,595 shares to 321,930 shares, a decline of 2.3% of his pre-transaction stake. The scheduled nature of the plan removes timing as an interpretable signal of his current conviction about the company's direction.

Director Farquhar Scott sells 7,665 shares of TEAM for $1,038,156.05 under pre-arranged 10b5-1 plan

Farquhar Scott, a director at Atlassian Corp, executed 5 separate sales totaling 7,665 shares for $1,038,156.05 on 2026-01-28 at a blended average price of $135.44. The transaction was conducted under a pre-arranged 10b5-1 trading plan adopted on 2025-02-12, making it scheduled rather than discretionary. Following the sales, Scott retained 329,595 shares, representing a 2.3% reduction from his pre-transaction holdings of 337,260 shares. As a scheduled disposition under a pre-established trading plan, this filing reflects an automated execution aligned with a predetermined schedule rather than a response to current market conditions.

CEO Cannon-Brookes sells 7,665 shares of TEAM for $1.0M under pre-arranged 10b5-1 plan

Atlassian CEO Michael Cannon-Brookes executed 5 separate sales totaling 7,665 shares for $1,038,152.64 on 2026-01-28, reducing his holdings from 337,260 shares to 329,595 shares (-2.3%). The transactions were priced between $134.67 and $138.59 with a blended average of $135.44. This sale was conducted under a pre-arranged 10b5-1 trading plan adopted on 2025-02-20, meaning the timing and volume were scheduled in advance rather than discretionary. As a scheduled divestiture representing a small fraction of his remaining stake, this filing is routine portfolio activity with no indication of material concern regarding the company's near-term trajectory.